Browse the detailed record of transactions filed by Anders Rylander, 首席执行官. Insider active across 2 companies, notably Biovica International AB. Cumulatively, 2 disclosures have been logged. History available since 14 March 2025. The latest transaction was filed on 27 August 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Anders Rylander is the Chief Executive Officer of Biovica International AB. In this role, he is responsible for the strategic direction of the company and the management of its operations. Biovica International AB is a biopharmaceutical company specializing in developing diagnostic tests.